全文获取类型
收费全文 | 106488篇 |
免费 | 5368篇 |
国内免费 | 4383篇 |
专业分类
林业 | 7124篇 |
农学 | 7777篇 |
基础科学 | 4079篇 |
13355篇 | |
综合类 | 27645篇 |
农作物 | 4890篇 |
水产渔业 | 4052篇 |
畜牧兽医 | 38798篇 |
园艺 | 2113篇 |
植物保护 | 6406篇 |
出版年
2022年 | 1533篇 |
2021年 | 2036篇 |
2020年 | 2010篇 |
2019年 | 2019篇 |
2018年 | 1823篇 |
2017年 | 2307篇 |
2016年 | 2115篇 |
2015年 | 2558篇 |
2014年 | 2507篇 |
2013年 | 4313篇 |
2012年 | 4097篇 |
2011年 | 4510篇 |
2010年 | 3680篇 |
2009年 | 3395篇 |
2008年 | 3810篇 |
2007年 | 3642篇 |
2006年 | 3491篇 |
2005年 | 3299篇 |
2004年 | 2262篇 |
2003年 | 2243篇 |
2002年 | 2038篇 |
2001年 | 2258篇 |
2000年 | 2286篇 |
1999年 | 2184篇 |
1998年 | 1352篇 |
1997年 | 1256篇 |
1996年 | 1159篇 |
1995年 | 1276篇 |
1994年 | 1111篇 |
1993年 | 1038篇 |
1992年 | 1852篇 |
1991年 | 1822篇 |
1990年 | 1839篇 |
1989年 | 1774篇 |
1988年 | 1633篇 |
1987年 | 1539篇 |
1986年 | 1529篇 |
1985年 | 1458篇 |
1984年 | 1237篇 |
1983年 | 1068篇 |
1979年 | 1197篇 |
1978年 | 968篇 |
1975年 | 908篇 |
1974年 | 1183篇 |
1973年 | 1138篇 |
1972年 | 1170篇 |
1971年 | 1124篇 |
1970年 | 1054篇 |
1969年 | 910篇 |
1967年 | 875篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
ABSTRACT1. The objectives of the current study were to investigate the mitochondrial genome and molecular phylogeny of Lueyang black-bone chicken, and provide molecule base to preserve and explore the specific chicken strain.2. Based on sequencing and clustering, the complete mitochondrial DNA map and sequences of Lueyang black-bone chicken were revealed, and two phylogenetic trees of Lueyang black-bone chickens based on D-loop sequences and the mitochondrial genome were constructed.3. The results showed that the complete mitochondrial genome of Lueyang black-bone chickens is 16,784bp in size, consisting of 22 transfer RNA genes, two ribosomal RNA genes, 13 protein-coding genes, and one non-coding control region. The base composition of the complete mtDNA sequence is 30.28% for A, 23.78% for T, 32.42% for C, 13.52% for G. Additionally, 10 haplotypes of D-loop sequences in 32 Lueyang black-bone chickens were detected, which were distributed into 4 clades (A, B, C and E).4. It was concluded that genetic diversity is wide in Lueyang black-bone chickens, and this strain has multiple maternal origins from different regions in China and neighbouring regions. 相似文献
993.
M. L. Stock S. T. Elazab W. H. Hsu 《Journal of veterinary pharmacology and therapeutics》2018,41(2):184-194
Triazines are relatively new antiprotozoal drugs that have successfully controlled coccidiosis and equine protozoal myeloencephalitis. These drugs have favorably treated other protozoal diseases such as neosporosis and toxoplasmosis. In this article, we discuss the pharmacological characteristics of five triazines, toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril which are used in veterinary medicine to control protozoal diseases which include coccidiosis, equine protozoal myeloencephalitis, neosporosis, and toxoplasmosis. 相似文献
994.
Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild‐to‐moderate clinical mastitis in dairy cows with longer lasting udder diseases 下载免费PDF全文
M. Ziesch N. Wente Y. Zhang W. Zaremba S. Engl V. Krömker 《Journal of veterinary pharmacology and therapeutics》2018,41(1):11-21
A nonblinded, positively controlled, noninferiority trial was conducted to evaluate the efficacy of an alternative, nonantibiotic therapy with Masti Veyxym® to reduce ineffective antibiotic usage in the treatment of nonsevere clinical mastitis (CM) in cows with longer lasting udder diseases. The solely intramammary treatment with Masti Veyxym® (three applications, 12 hr apart) and the combined treatment with Masti Veyxym® and antibiotics as usual on the farm according to label of the respective product were compared with the reference treatment of solely antibiotic therapy. The matched field study was conducted on eight free‐stall dairy farms located in Eastern Germany. Cases of mild‐to‐moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation were randomly allocated to one of the three treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 14 days and 21 days after the end of therapy for cyto‐bacteriological examination. Primary outcomes were clinical cure (CC) and no CM recurrence within 60 days after the end of treatment (no R60). Bacteriological cure (BC) and quarter somatic cell count (QSCC) cure were chosen as secondary outcomes although low probabilities of BC and QSCC cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Streptococcus uberis, followed by Staphylococcus aureus and coagulase‐negative staphylococci. There were no significant differences between the two test treatments in comparison with the reference treatment regarding all outcome variables. The sole therapy with Masti Veyxym® resulted in a numerically lower likelihood of BC without significant differences to the reference treatment. The combined therapy group showed a numerically higher nonrecurrence rate than the two other treatment groups and noninferiority compared to the reference treatment was proven. Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Masti Veyxym® in nonsevere CM cases may constitute an alternative therapy to reduce antibiotics. However, noninferiority evaluations were mostly inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a clear statement on noninferiority. 相似文献
995.
Li F. K. Yang Y. Jenna K. Xia C. H. Lv S. J. Wei W. H. 《Tropical animal health and production》2018,50(8):1893-1901
Tropical Animal Health and Production - This study was conducted to investigate the effects of heat stress on the behavioral and physiological patterns in Small-tail Han sheep housed indoors in... 相似文献
996.
997.
In vitro anti‐LPS dose determination of ketorolac tromethamine and in vivo safety of repeated dosing in healthy horses 下载免费PDF全文
A. W. Bianco G. E. Moore B. R. Cooper S. D. Taylor 《Journal of veterinary pharmacology and therapeutics》2018,41(1):98-104
Flunixin meglumine (FM) is a commonly used Nonsteroidal anti‐inflammatory drug (NSAID) in horses, but clinical efficacy is often unsatisfactory. Ketorolac tromethamine (KT) demonstrates superior efficacy compared to other NSAIDs in humans, but its anti‐inflammatory effects have not been investigated in the horse. Safety of repeated dosing of KT has not been evaluated. The first objective was to conduct a dose determination study to verify that a previously described dosage of KT would inhibit Lipopolysaccharide (LPS)‐induced eicosanoid production in vitro, and to compare KT effects of this inhibition to those of FM. Then, a randomized crossover study was performed using nine healthy horses to evaluate plasma concentrations of KT and FM following IV administration. Administered dosages of KT and FM were 0.5 mg/kg and 1.1 mg/kg, respectively. Safety following six repeated doses of KT was assessed. Ketorolac tromethamine and FM suppressed LPS‐induced Thromboxane B2 (TXB2) and Prostaglandin E2 (PGE2) production in vitro for up to 12 hr. Intravenous administration produced plasma concentrations of KT and FM similar to previous reports. No adverse effects were observed. A KT dosage of 0.5 mg/kg IV inhibited LPS‐induced eicosanoids in vitro, and repeated dosing for up to 3 days appears safe in healthy horses. Investigation of in vivo anti‐inflammatory and analgesic effects of KT is warranted. 相似文献
998.
999.
1000.